Back to search

Pain Management in Response to Exparel vs. Standard Bupivicaine

NCT02499159

PHASE4INTERVENTIONAL
Inova Health Care Services
100 participants
Started 2014-12 · Completed 2017-07
Status: Completed (as of 12-23-2025)

Conditions

Pain

Interventions

DRUG: Liposomal BupivicaineDRUG: 0.25% standard bupivicaine

Linked Papers (from SciSciNet-V2)

Total Papers5
Background
1
Result
0
Derived
0
Unknown
4
View on ClinicalTrials.gov

Total Citations Per Year

Brief Summary

This study is looking to evaluate the efficacy of liposomal bupivicaine (Exparel) on decreasing the amount of consumed pain medications. Patients will be randomly selected to received either Exparel or standard bupivicaine injection during surgery. Patients will be followed up to assess pain levels using a visual pain scale, and to assess how much pain medication was consumed.

Sort by:

Background Papers2

A Randomized Controlled Trial of Bupivacaine Through Intracostal Catheters for Pain Management After Thoracotomy
2009
18 citations
A Randomized Controlled Trial of Bupivacaine Through Intracostal Catheters for Pain Management After Thoracotomy
2009
18 citations

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked

Unknown Papers4

Surgery for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review of the Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Approaches to Lobectomy
2008
606 citations
Prospective, randomized comparison of extrapleural versus epidural analgesia for postthoracotomy pain
1998
128 citations
Continuous epidural or intercostal analgesia following thoracotomy: a prospective randomized double‐blind clinical trial
2003
80 citations
Analgesic and pulmonary effects of continuous intercostal nerve block following thoracotomy
1991
64 citations